NCT05083377

Brief Summary

CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 8, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 19, 2021

Completed
Last Updated

October 19, 2021

Status Verified

October 1, 2021

Enrollment Period

1 year

First QC Date

October 6, 2021

Last Update Submit

October 6, 2021

Conditions

Schizophrenia and Related Disorders

Keywords

clozapine

Outcome Measures

Primary Outcomes (1)

  • Identify the pattern of clozapine use in the province of Seville

    Identify the pattern of clozapine use in the province of Seville

    year 2018

Secondary Outcomes (2)

  • Analyze the variability between centers or professionals

    year 2018

  • Analyze the changes in the course of the disease since the prescription of clozapine

    year 2018

Study Arms (1)

Patients who have been prescribed clozapine during 2018

Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.

You may qualify if:

  • Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.

You may not qualify if:

  • Parkinson's disease
  • Dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Virgen del Rocío

Seville, 41013, Spain

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Benedicto Crespo Facorro, Professor

    benedicto.crespo.sspa@juntadeandalucia.es

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2021

First Posted

October 19, 2021

Study Start

September 8, 2020

Primary Completion

September 8, 2021

Study Completion

September 8, 2021

Last Updated

October 19, 2021

Record last verified: 2021-10

Locations

ES(1)